NeuBase Therapeutics, Inc. (NBSE)

NASDAQ: NBSE · IEX Real-Time Price · USD

0.411

-0.009 (-2.12%)

At close: Apr 19, 2024, 8:53 AM

0.410

-0.001 (-0.24%)

Pre-market: Apr 19, 2024, 8:53 AM EDT

NeuBase Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2005
Cash & Equivalents	23.15	52.89	31.99	10.31	0.25	12.8	12.55	28.7	13.22	5.12	Upgrade
Cash & Cash Equivalents	23.15	52.89	31.99	10.31	0.25	12.8	12.55	28.7	13.22	5.12	Upgrade
Cash Growth	-56.23%	65.33%	210.18%	4032.20%	-98.05%	2.03%	-56.28%	117.07%	158.07%	94.61%	Upgrade
Other Current Assets	1.5	2.04	0.82	0.72	0	0.22	0.74	0.34	0.13	0.05	Upgrade
Total Current Assets	24.65	54.93	32.81	11.03	0.25	13.02	13.29	29.04	13.35	5.17	Upgrade
Property, Plant & Equipment	7.77	8.41	1.17	0.43	0	0.06	0.2	0.25	0.1	0.03	Upgrade
Long-Term Investments	0	0.42	0.32	0.59	0	0	0	0	0	0	Upgrade
Goodwill and Intangibles	0	0	0	0.15	0	14.83	15.95	17.07	18.55	0.55	Upgrade
Other Long-Term Assets	0.27	0.41	0.15	0.34	0	0.01	0.01	0.01	0.01	0	Upgrade
Total Long-Term Assets	8.04	9.24	1.64	1.5	0	14.9	16.16	17.33	18.67	0.58	Upgrade
Total Assets	32.69	64.17	34.44	12.53	0.25	27.93	29.45	46.37	32.03	5.74	Upgrade
Accounts Payable	1.84	1.81	1.51	1.48	0.02	4.83	4.39	1.59	0.35	0.47	Upgrade
Current Debt	0.66	0.64	0.14	0.12	0	0.11	0.09	0.05	0.04	0.01	Upgrade
Other Current Liabilities	1.66	1.75	1.51	0.9	0.02	0	0	2.24	4.88	0	Upgrade
Total Current Liabilities	4.17	4.19	3.15	2.5	0.04	4.93	4.48	3.88	5.27	0.48	Upgrade
Long-Term Debt	5.34	5.9	0	0	0.25	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	0	0	0	0	0	0.15	0	0	0	0	Upgrade
Total Long-Term Liabilities	5.34	5.9	0	0	0.25	0.15	0	0	0	0	Upgrade
Total Liabilities	9.5	10.1	3.15	2.5	0.29	5.08	4.48	3.88	5.27	0.48	Upgrade
Total Debt	6	6.54	0.14	0.12	0.25	0.11	0.09	0.05	0.04	0.01	Upgrade
Debt Growth	-8.35%	4621.66%	12.72%	-50.83%	134.99%	21.17%	82.67%	9.49%	212.43%	-36.24%	Upgrade
Retained Earnings	-102.74	-68.97	-43.56	-26.17	-0.04	-108.09	-84.28	-58.51	-43.31	-34.18	Upgrade
Shareholders' Equity	23.19	54.07	31.29	10.03	-0.04	22.84	24.96	42.49	26.75	5.26	Upgrade
Net Cash / Debt	17.16	46.35	31.85	10.19	-0	12.69	12.46	28.65	13.18	5.11	Upgrade
Net Cash / Debt Growth	-62.99%	45.51%	212.57%	-	-	1.89%	-56.51%	117.43%	157.92%	95.71%	Upgrade
Net Cash Per Share	10.56	33.95	32.47	24.64	-0.00	113.42	158.97	403.45	238.04	109.24	Upgrade
Working Capital	20.48	50.73	29.66	8.53	0.21	8.09	8.8	25.16	8.08	4.69	Upgrade
Book Value Per Share	14.28	39.60	31.90	24.25	-0.30	204.11	318.52	598.37	483.29	112.56	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).